SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oliver & Co who wrote (3214)12/8/1997 9:13:00 PM
From: Oliver & Co   of 6136
 
"AIDS Panel to Clinton: Leadership Is Lacking"
USA Today (12/08/97) P. 2A; Hall, Mimi
ÿÿÿÿ In its second progress report, the Presidential Council on
HIV/AIDS criticizes the Clinton administration for failing to
demonstrate a "coherent plan of action" against AIDS, despite the
abundance of evidence indicating the effectiveness of
preventative efforts.ÿ Specifically, the panel reports that
funding for prevention is inadequate compared to the cost of
medical care; too few Americans have access to effective medical
treatments; and the White House has failed to expand Medicaid to
cover all low-income people in the early stages of HIV infection.
The panel also urged the administration to encourage removal of
the ban on federal funding for needle-exchange programs.ÿ In
response to the report, Sandra Thurman--director of the Office of
National AIDS Policy--attributed the "sense of diminished
priority for AIDS issues" to the fact that the Clinton
administration's greatest strides occurred in the first term.ÿ In
fact, overall funding for federal AIDS research has risen since
Clinton took office in 1993.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext